These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 16154358)
1. Astatination of nanoparticles containing silver as possible carriers of 211At. Kucka J; Hrubý M; Konák C; Kozempel J; Lebeda O Appl Radiat Isot; 2006 Feb; 64(2):201-6. PubMed ID: 16154358 [TBL] [Abstract][Full Text] [Related]
2. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925 [TBL] [Abstract][Full Text] [Related]
3. A new internal target system for production of (211)At on the cyclotron U-120M. Lebeda O; Jiran R; Rális J; Stursa J Appl Radiat Isot; 2005 Jul; 63(1):49-53. PubMed ID: 15866447 [TBL] [Abstract][Full Text] [Related]
4. Controlling transport and chemical functionality of magnetic nanoparticles. Latham AH; Williams ME Acc Chem Res; 2008 Mar; 41(3):411-20. PubMed ID: 18251514 [TBL] [Abstract][Full Text] [Related]
5. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 3: alpha-particle-induced radiolytic effects on the chemical behavior of (211)At. Pozzi OR; Zalutsky MR J Nucl Med; 2007 Jul; 48(7):1190-6. PubMed ID: 17574991 [TBL] [Abstract][Full Text] [Related]
6. Silver nanoparticle formation in microemulsions acting both as template and reducing agent. Andersson M; Pedersen JS; Palmqvist AE Langmuir; 2005 Nov; 21(24):11387-96. PubMed ID: 16285815 [TBL] [Abstract][Full Text] [Related]
7. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers. Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256 [TBL] [Abstract][Full Text] [Related]
8. Preparation and study of polyacryamide-stabilized silver nanoparticles through a one-pot process. Chen M; Wang LY; Han JT; Zhang JY; Li ZY; Qian DJ J Phys Chem B; 2006 Jun; 110(23):11224-31. PubMed ID: 16771388 [TBL] [Abstract][Full Text] [Related]
9. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. Stevens KN; Crespo-Biel O; van den Bosch EE; Dias AA; Knetsch ML; Aldenhoff YB; van der Veen FH; Maessen JG; Stobberingh EE; Koole LH Biomaterials; 2009 Aug; 30(22):3682-90. PubMed ID: 19394689 [TBL] [Abstract][Full Text] [Related]
10. The fabrication of periodic polymer/silver nanoparticle structures: in situ reduction of silver nanoparticles from precursor spatially distributed in polymer using holographic exposure. Smirnova TN; Kokhtych LM; Kutsenko AS; Sakhno OV; Stumpe J Nanotechnology; 2009 Oct; 20(40):405301. PubMed ID: 19752504 [TBL] [Abstract][Full Text] [Related]
11. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. Kocbek P; Obermajer N; Cegnar M; Kos J; Kristl J J Control Release; 2007 Jul; 120(1-2):18-26. PubMed ID: 17509712 [TBL] [Abstract][Full Text] [Related]
12. Influence of oxygen on the optical properties of silver nanoparticles. Renteria-Tapia VM; García-Macedo J J Nanosci Nanotechnol; 2008 Dec; 8(12):6545-50. PubMed ID: 19205238 [TBL] [Abstract][Full Text] [Related]
15. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Devalapally H; Shenoy D; Little S; Langer R; Amiji M Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429 [TBL] [Abstract][Full Text] [Related]
17. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification. Rosenblatt KM; Bunjes H Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of silver ion reduction in concentrated solutions of amphiphilic invertible polyesters in nonpolar solvent at room temperature. Voronov A; Kohut A; Vasylyev S; Peukert W Langmuir; 2008 Nov; 24(21):12587-94. PubMed ID: 18828624 [TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
20. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate. Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]